Page 2 - Krish Krishnan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Adaptive Biotechnologies (NASDAQ:ADPT – Get Rating) and Krystal Biotech (NASDAQ:KRYS – Get Rating) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings and risk. Volatility & Risk Adaptive Biotechnologies has a beta of 1.18, […]

Krystal Biotech (NASDAQ:KRYS – Get Rating) and Neurocrine Biosciences (NASDAQ:NBIX – Get Rating) are both mid-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, analyst recommendations, earnings, risk and profitability. Profitability This table compares Krystal Biotech and Neurocrine Biosciences’ […]

FDA Approval, Private Placement Funding Buoy Biotech Firm

The U.S. Food and Drug Administration recently approved a treatment called Vyjuvek – the first gene therapy for sale that is applied to the outside of a patient's body. The treatment, [...]

About 9,000 to 10,000 people suffer from dystrophic epidermolysis bullosa globally